FACDX
Price
$64.38
Change
+$0.13 (+0.20%)
Updated
Sep 11 closing price
Net Assets
3.34B
SHSAX
Price
$62.92
Change
-$0.10 (-0.16%)
Updated
Sep 11 closing price
Net Assets
6.17B
Interact to see
Advertisement

FACDX vs SHSAX

FACDX vs SHSAX Comparison Chart in %
View a ticker or compare two or three
VS
FACDX vs. SHSAX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FACDX is a Hold and SHSAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SHSAX has more cash in the bank: 6.17B vs. FACDX (3.34B). SHSAX pays higher dividends than FACDX: SHSAX (0.26) vs FACDX (0.00). FACDX was incepted earlier than SHSAX: FACDX (30 years) vs SHSAX (27 years). SHSAX (1.09) is less costly to investors than FACDX (0.93). FACDX is a more actively managed with annual turnover of: 52.00 vs. SHSAX (43.00). FACDX initial investment is less costly to investors than SHSAX (5%) vs SHSAX (5%). FACDX has a lower initial minimum investment than SHSAX: FACDX (0) vs SHSAX (1000). FACDX annual gain was more profitable for investors over the last year : 12.84 vs. SHSAX (4.10). FACDX return over 5 years is better than : -9.39 vs. SHSAX (-17.90).
FACDXSHSAXFACDX / SHSAX
Total Expense Ratio0.931.0985%
Annual Report Gross Expense Ratio0.931.0985%
Fund Existence30 years27 years-
Gain YTD14.385-2.642-545%
Front Load6%5%110%
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.34B6.17B54%
Annual Yield % from dividends0.000.26-
Returns for 1 year12.844.10313%
Returns for 3 years11.49-2.23-514%
Returns for 5 years-9.39-17.9052%
Returns for 10 years73.3134.80211%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOHU13.680.18
+1.30%
Sohu.com Limited
BHFAM9.79N/A
N/A
Brighthouse Financial
VNET6.33-0.05
-0.78%
VNET Group
EAT212.49-2.20
-1.02%
Brinker International
GRCE2.22-0.04
-1.77%
Grace Therapeutics Inc